Post
Fipco
fipco.bsky.social
did:plc:3jl2vdjms3jwwgc3uvr6vzak
NCT03915964 and NCT04086745 have yet to report. Primary completion date of trial was May 2025. Nearly 4k randomized patients followed multiple years assessing JAKi safety. Potential release this month. #baricitinib
https://bsky.app/profile/fipco.bsky.social/post/3m6ulce4kmc2a
[contains quote post or other embedded content]
2026-05-05T13:40:32.964Z